Literature DB >> 8333924

Autoimmune recognition of cartilage collagens.

R Holmdahl1, V Malmström, E Vuorio.   

Abstract

Recent advances in basic research on the immune system and molecular biology of cartilage components have greatly increased our understanding of the role of autoimmunity in inflammatory diseases affecting joints, particularly rheumatoid arthritis. Many of these diseases are common and their complex pathogenesis probably involves a large number of genes polymorphic in the population as well as environmental factors. Characteristic features of inflammatory arthritis include expansion of the synovial tissue into a pannus containing lymphocytes and macrophages, autoimmune reactions against cartilage antigens, and erosion of cartilage. Since hyaline cartilage of the articular surfaces is the only structure within the joint known to contain joint-specific antigens this tissue is the prime suspect as the target of the autoimmune This review will first present the capacity of the immune system to discriminate between self and non-self structures, and then summarize our current understanding of the structures of cartilage collagens. Subsequently we will discuss how the immune system normally interacts with cartilage and how such interactions can lead to arthritis. We propose that collagen-induced arthritis (CIA) is valuable for understanding the autoimmune recognition of cartilage collagen which precedes the outbreak of arthritis and may perpetuate its chronicity, and serves as an animal model of rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333924     DOI: 10.3109/07853899309147871

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  8 in total

1.  Evaluating candidate autoantigens in rheumatoid arthritis.

Authors:  A P Cope; G Sønderstrup
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis.

Authors:  Sirish K Ippagunta; David D Brand; Jiwen Luo; Kelli L Boyd; Christopher Calabrese; Rinke Stienstra; Frank L Van de Veerdonk; Mihai G Netea; Leo A B Joosten; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

3.  Immunization with T cell receptor V beta chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice.

Authors:  T M Haqqi; X M Qu; D Anthony; J Ma; M S Sy
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

Review 4.  The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies.

Authors:  I E Lundberg
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

5.  Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis.

Authors:  V Malmström; E Michaëlsson; H Burkhardt; R Mattsson; E Vuorio; R Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

6.  Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase.

Authors:  Robert Bockermann; David Schubert; Thomas Kamradt; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2005-09-20       Impact factor: 5.156

Review 7.  Lessons from animal models of arthritis over the past decade.

Authors:  Wim B van den Berg
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

8.  Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice.

Authors:  Ingrid Lindh; Omri Snir; Erik Lönnblom; Hüseyin Uysal; Ida Andersson; Kutty Selva Nandakumar; Michel Vierboom; Bert 't Hart; Vivianne Malmström; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2014-07-08       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.